Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-11-08

Clinical Trial Update: LMWH Infusion as Anticoagulation for Home HD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating low molecular weight heparin infusion as anticoagulation for home hemodialysis in patients with end-stage renal disease. Curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Alice Ho Miu Ling Nethersole Hospital | Conditions: Endstage Renal Disease | Phase 4 | Status: UNKNOWN